Navigation Links
Amylin Pharmaceuticals Reports 2010 Financial Results
Date:1/26/2011

as $152.3 million, or $1.06 per share, for the year ended December 31, 2010, compared to $186.3 million, or $1.32 per share for 2009.

Conference CallAmylin will webcast its Quarterly Update and Year End Conference Call today at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. During the call, the Company plans to provide further details underlying its fourth quarter and 2010 financial results. A slide presentation accompanying the conference call will be available through the "Investors" section of Amylin's corporate website at www.amylin.com.

To access the webcast, please log on to the website approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (800) 857-5738 (U.S./Canada) or (415) 228-4970 (international), participant passcode number 75593. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (888) 567-0472 (U.S./Canada) or (203) 369-3447 (international).

Note Regarding Use of Non-GAAP Financial Measures Amylin reports non-GAAP operating income/(loss) excluding non-cash items and other items such as restructuring charges, which is a non-GAAP financial measure. The Company believes that investors' understanding of its progress towards its previously stated goal of generating sustainable positive non-GAAP operating results is enhanced by this disclosure. In addition, the Company refers to this non-GAAP financial information with its analysis of the Company's financial performance. This non-GAAP financial measure should be considered in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.

About Amylin PharmaceuticalsAmylin Pharmaceuticals
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
2. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
4. Amylin Pharmaceuticals Reports Third Quarter Financial Results
5. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
6. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
7. Amylin Pharmaceuticals to Webcast Third Quarter Results
8. Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010
9. Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
10. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
11. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  EP Global Communications, Inc. (OTC-PINK: EPGL) In ... opened negotiations with CooperVision, Inc. at $1.1 billion ... ophthalmic technologies. As previously disclosed publicly, CooperVision, Inc. ... contact lens technologies, which has led to several ... industry experts that just one of these newly ...
(Date:3/30/2015)... AUSTIN, Texas , March 30, 2015 ... highlight the My Diabetes Emergency Plan at the 2015 ... encourage you to be prepared to manage your #diabetes ... of Endocrinology (ACE) – the charitable, educational and scientific ... – has joined forces with Lilly Diabetes to share ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research ... announced the addition of the "Computer Aided ... report to their offering. Annual estimates ... through 2020. Also, a six-year historic analysis is ... are derived from primary and secondary research. Company ...
Breaking Medicine Technology:CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 2CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 3Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 2Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 3Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 4
... Digestive Disease Week (DDW), SAN DIEGO, May ... Digestive Disease Week reaffirm the long-term, sustainable,efficacy and ... in,treating patients with moderate to severe Crohn,s disease. ... responders and the remission,rate remained stable in many ...
... US Employer Claims Suggests a Benefit,of Anti-Tumor Necrosis Factor Therapies on ... ... 20 Data from a new analysis of the,Active Ulcerative Colitis ... than 60 percent of patients with moderately to severely active,ulcerative colitis ...
Cached Medicine Technology:Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8
(Date:3/30/2015)... (PRWEB) March 30, 2015 “ iCareTech ” ... Report, which takes a look at the latest and coolest ... NewsWatch special reporter and technology expert, conducted the review and ... band that’s dedicated to the medical and health fields. , ... of conversation over the past couple of years. Well, at ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an article ... new treatment options for dealing with stubborn, unwanted fat. Two ... product. The other three technologies use devices to deliver ultrasound ... cold ( CoolSculpting ) to kill fat cells. (see: goo.gl/NmaB4q) ... to permanently remove unwanted fat," says Dr. Simon Ourian, Medical ...
(Date:3/30/2015)... March 30, 2015 Healthy, radiant skin ... Pharmacy. The staff of pharmacists is specially trained and ... like acne, eczema and other conditions. , Most people ... patient’s dermatologist and/or PCP to tackle most skin conditions ... Pharmacy has employed specialty-trained pharmacists who have experience in ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical ... it is expanding its services into Asia in 2015. ... the world comes at a time when Asia’s strengthening ... better healthcare. A rapidly growing aging population and changing ... in medicine in Asia. “We are excited to be ...
(Date:3/30/2015)... York, NY (PRWEB) March 30, 2015 ... and other neurological diseases plays an important role in ... led by scientists from the Icahn School of Medicine ... , Neurological diseases have long been associated with inflammation, ... that occurs when immune cells home in to attack ...
Breaking Medicine News(10 mins):Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3
... Isabelle Taylor, of St Annes, Lancs, a mobile phone two ... would end up constantly // sending text messages to her ... ‘repetitive strain injury’ and becoming the youngest person in Britain ... explains that she's constantly on the phone messaging. Stating that ...
... the people who are undergoing fertility treatment do not ... apprehensive // about the repercussions .In a survey carried out ... approximately 300 patients, it was observed that the patients ... of their bosses. The survey, done for ...
... of the University of Portsmouth and colleagues a large number ... food intakes because their parents believed that they are ... 54 per cent of a sample group of one-year-olds were ... such food items initiated an allergic reaction in them ...
... properties very close to insulin, bringing hope to the thousands of ... by DIA-B, a biotech company whose chairman is the former federal ... apply for a patent, so your guess is as good as ... Dr Wooldridge, 'The medical and commercial potential this represents would be ...
... by McGill University in Montreal it was found that vitamin ... // . The sun shine vitamin as it is called ... It was also found that pregnant women consuming too little ... Canada, US and Australia met in Toronto and discussed the ...
... that patients who come for emergency treatment at Victoria Hospital ... The emergency ward at the hospital is said to be ... of beds. This has been further worsened with one of ... the last four months. ,He hospital sources have ...
Cached Medicine News:Health News:Role of Vitamin D in Preventing Cancer 2Health News:Victoria Hospital In Bangalore is Lacking Beds In Emergency wards 2
... Plus Chemistry Analyzer is an in vitro ... of clinical chemistry parameters using Reflotron Test Tabs. ... and ensures rapid and reliable results while being ... clear LC display and the profile can be ...
... ASR contains primers and a FAM-labeled probe targeting ... the Parvo B19 ASR contains primers and a ... This ASR requires an instrument that can detect ... System., The Cepheid Analyte Specific Reagent* (ASR) program ...
... Enterovirus ASR contains primers, a FAM-labeled probe and ... detect a 115 bp region of the 5' ... detect FAM, Alexa 532 and Texas Red reporter ... Analyte Specific Reagent* (ASR) program is comprised of ...
... The B. pertussis ASR contains primers and ... a 103 bp region of the IS481 gene. ... a Texas Red-labeled probe and DNA for an ... that can detect FAM and Texas Red reporter ...
Medicine Products: